Conference Coverage
Feature
What Matters Most for Young Patients With CRC: Survey Highlights Top Concerns
Cancer is ‘impacting younger people who are in important developmental stages of their lives.’
Conference Coverage
AI-Assisted Colonoscopy Linked to Higher Rate of Benign Lesion Removal
The findings indicate that full adoption of AIAC could result in about 600,000 more colonoscopies in which only benign, nonadenomatous lesions are...
Conference Coverage
ATA: Updates on Risk, Diagnosis, and Treatment of Thyroid Cancer
Researchers compared medical records of adults with type 2 diabetes and moderate cardiovascular risk who were new users of GLP-1 receptor agonists...
Conference Coverage
Low-Volume Bowel Prep Easier, as Effective as Standard Prep in Hospitalized Patients
The rates of electrolyte abnormalities and acute kidney injury were low and similar between the two groups.
Conference Coverage
GLP-1 RAs Reduce Early-Onset CRC Risk in Patients With Type 2 Diabetes
The incidence of early-onset colorectal cancer is notably rising in younger adults, with a corresponding increase in associated mortality.
Conference Coverage
AI Tool Helps Detect, Differentiate Pancreatic Lesions During Endoscopic Ultrasound
Endoscopic ultrasound is the “gold standard” for pancreatic lesion evaluation, but its diagnostic accuracy is suboptimal, particularly for lesions...
Conference Coverage
When It Comes to Polyp Diagnosis With CADx, Location Matters
“The key questions here relate to why are these systems underperforming in the proximal colon, and how can we improve this?” said Dr. David Graham...
Latest News
Study Finds Elevated Skin Cancer Risk Among US Veterans
Compared with nonveterans, veterans were more likely to have been diagnosed with skin cancer at some point in their lives.
Conference Coverage
Cancer’s Other Toll: Long-Term Financial Fallout for Survivors
Patients with cancer face a range of financial challenges that often lasted years following their diagnosis.
Conference Coverage
Mortality Rates From Early-Onset CRC Have Risen Considerably Over Last 2 Decades
Increased mortality occurred across all patients included in the study (aged 20-54) regardless of tumor stage at diagnosis.
Conference Coverage
Multi-Refractory MM: After Immunotherapy, What?
Experts outlined viable remaining options for treating multi-refractory myeloma, following immunotherapy.